The PQE group launches an AI and data analysis division: innovation in the service of life sciences
The Italian consulting group, with over 45 global branches, invests in artificial intelligence: creating a new department and a strategic partnership for a forward-thinking and responsible future.
| BioBuzz has been building life sciences communities for 14 years because we believe in the power of personal networks to unlock your career potential. For our next chapter, we’re building on the success of our community to help solve today’s biggest hiring and career development challenges. There is a better, fairer way to connect talent to opportunity… and we build it. |
Florence, Italy, June 25, 2024 – PQE Groupleading consulting firm in the life sciences sector, announces the consolidation of its new Regulated Artificial Intelligence and Data Analytics division, in operation since the launch of AI-based tools in the industrial sector. This is a pivotal step in the company’s evolution, positioning the Italian group, made up of more than 2,000 employees, at the forefront of technological innovation in life sciences. The new division is designed to improve the effectiveness and efficiency of business processes while ensuring regulatory compliance. Leveraging advanced technologies, PQE Group offers services such as AI-based decision optimization, risk reduction and accelerated innovation, all in compliance with industry regulations. The Stanford AI Report 2024 highlighted the important role of AI in accelerating scientific discovery in 2022, with further strengthening in 2023.
“Regulators have started to respond to expectations regarding these solutions, but much remains to be done, as regulated companies need detailed guidance on the documentation required to ensure the explainability and performance of each tool,” highlighted Danilo Neri, Partner and Executive Vice President of PQE Group. “Just a few weeks ago, the final approval of the AI Act in the European Union was granted, which represents the most advanced regulation in the world on artificial intelligence, requiring documentation to address explainability. This is an important step, but it is equally important that sanctions are effectively applied to offenders so as not to compromise the protection of consumers, workers and citizens to the detriment of innovation and market competitiveness. The full implementation of this division will allow us to consolidate our position as an industry leader, offering exceptional compliance approaches and tailor-made solutions to our clients that meet regulatory expectations and the increasingly complex needs of the market.” » PQE Group’s dedicated validation approach has been designed to meet today’s regulatory expectations for machine learning-based tools and generative AI solutions.
PQE Group’s partnership with Canadian company GenAIz will further increase service capacity. GenAIz, focused on using AI to serve humanity, has developed a platform to accelerate decision-making and execution through better business insights. This collaboration will enhance PQE Group’s ability to deliver innovative solutions and the necessary validation packages required by GxP regulations and new industry-wide rules (e.g. EU AI Law). Led by Catherine Lunardi, CEO of GenAIz and spokesperson at the G7 on AI and Wellbeing, GenAIz’s AI platform will leverage PQE Group’s global presence, which includes more than 45 offices worldwide .
The Regulated Artificial Intelligence and Data Analytics division will be featured at a panel discussion and networking event in Rockville, MD on July 17, 2024. Experts will discuss AI regulation and the future of life sciences, marking a significant innovation for the pharmaceutical and medical device industry.
The press and readers are warmly invited to this event.
Please RSVP and find more information by registering here: https://hubs.ly/Q02CMQrj0
PQE Group Press Service
Michela Lijoi
(email protected)
(email protected)
Tel.: +39 328 6353044
- About the Author
- Latest posts
BioBuzz is a community-led, experience-driven media and events company. BioBuzz highlights the latest regional news, industry professionals, jobs, events and resources for business and career growth. Thousands of people across the BioHealth Capital region and Greater Philadelphia subscribe to their weekly newsletter, which is the go-to source for industry updates.
